Zobrazeno 1 - 10
of 26
pro vyhledávání: '"HERVE CHAMBOST"'
Autor:
Amy D. Shapiro, Roshni Daniel Kulkarni, Margaret V Ragni, Herve Chambost, Johnny N Mahlangu, Johannes Oldenburg, Beatrice Nolan, Margareth C Ozelo, Meredith C Foster, Annemieke Willemze, Chris Barnowski, Nisha Jain, Bent Winding, Jennifer Dumont, Stefan Lethagen, Chris Barnes, K John Pasi
Publikováno v:
Blood Advances.
Long-term efficacy and safety of the extended half-life recombinant FIX Fc fusion protein (rFIXFc) has been established in previously treated patients with severe hemophilia B in 2 Phase 3 trials (B-LONG [NCT01027364] and Kids B-LONG [NCT01440946]) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b3492f3b3a5f76dd4bbf7bdc817f3eb
https://doi.org/10.1182/bloodadvances.2022009230
https://doi.org/10.1182/bloodadvances.2022009230
Autor:
Sophie, Susen, Yves, Gruel, Anne, Godier, Annie, Harroche, Herve, Chambost, Dominique, Lasne, Antoine, Rauch, Stephanie, Roullet, Pierre, Fontana, Jenny, Goudemand, Emmanuel, de Maistre, Valerie, Chamouard, Bénédicte, Wibaut, Pierre, Albaladejo, Claude, Négrier
Publikováno v:
Haemophilia : the official journal of the World Federation of HemophiliaREFERENCES. 25(5)
Emicizumab (HemlibraThe following text aims to provide a guide for the management of people with haemophilia A with inhibitor treated with emicizumab in case of bleeding or invasives procedures.The French network on inherited bleeding disorders (MHEM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::550a60643b8b1bdf500c3e8607bc5c16
https://pubmed.ncbi.nlm.nih.gov/31294904
https://pubmed.ncbi.nlm.nih.gov/31294904
Autor:
HERVE CHAMBOST, Johanna G. Van der Bom, Angelo Claudio Molinari, Beatrice Nolan, Samantha Gouw, Chris Van Geet, Johannes Oldenburg, Maria Elisa Mancuso
Publikováno v:
Haemophilia, 20(6), 747-755. Wiley-Blackwell
Clausen, N, Petrini, P, Claeyssens-Donadel, S, Gouw, S C, Liesner, R & PedNet and Research of Determinants of Inhibitor development (RODIN) Study Group 2014, ' Similar bleeding phenotype in young children with haemophilia A or B : a cohort study ', Haemophilia Online, vol. 20, no. 6, pp. 747-55 . https://doi.org/10.1111/hae.12470
Clausen, N, Petrini, P, Claeyssens-Donadel, S, Gouw, S C, Liesner, R & PedNet and Research of Determinants of Inhibitor development (RODIN) Study Group 2014, ' Similar bleeding phenotype in young children with haemophilia A or B : a cohort study ', Haemophilia Online, vol. 20, no. 6, pp. 747-55 . https://doi.org/10.1111/hae.12470
The bleeding phenotype has been suggested to differ between haemophilia A and B. More knowledge on the bleeding phenotype at initiation of treatment is important to optimize patient care. The aim of this study was to investigate the severity of the b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5c826325095fabbf34e2acd631fff67
https://doi.org/10.1111/hae.12470
https://doi.org/10.1111/hae.12470
Autor:
Ngoc Anh Thu Nguyen, Pascal Auquier, Any Beltran Anzola, Roseline D’oiron, Thierry Lambert, Céline Falaise, Christine Biron, Anne Lienhart, Jenny Goudemand, Antoine Rauch, Bénédicte Wibaut, Sabine Marie Castet, Dominique Desprez, Annie Harroche, Natalie Stieltjes, Annie Borel-Derlon, Marc Trossaërt, Amandine Celli, Benoît Guillet, Sophie Bayart, Marie-Anne Bertrand, Alexandra Fournel, Guillaume Mourey, Valérie Gay, Pierre Chamouni, Emmanuelle DE Raucourt, Birgit Frotscher, Michèle Martin, Mathieu Puyade, Brigitte Tardy, Stéphane Vanderbecken, Fabienne Genre-Volot, Philippe Nguyen, Benoît Polack, Caroline Oudot-Challard, Stéphane Girault, Annelise Voyer, Aurélien Lebreton, Abel Hassoun, Philippe Moreau, Pierre-Simon Rohrlich, Karine Baumstarck, Mohamed Boucekine, Vanessa Milien, Natacha Rosso, Clemence Tabele, Marie Viprey, Nicolas Giraud, Thomas Sannie, Hervé Chambost, Noémie Resseguier
Publikováno v:
HemaSphere, Vol 7, p e623777c (2023)
Externí odkaz:
https://doaj.org/article/35f0ccb00974432f92e9847dd92e5503
Autor:
Sylvain P Chantepie, Despina Moshous, Norbert IFRAH, Didier Bouscary, Nicolas Cagnard, Catherine Paillard, Raphael Borie, Marlene Rio, Mohamad Mohty, HERVE CHAMBOST, Jean-Marie Michot, Nizar MAHLAOUI, Philippe Moreau, Eric Jeziorski, Sarah BEAUSSANT COHEN, Eric DECONINCK, Nicolas Schleinitz, Louis Terriou, Aurore Perrot, Mathilde Hunault, Elizabeth Anne Macintyre-Davi, Jean-Francois Schved, Olivier Hermine, Jean-francois BRASME, Guillaume LEFEVRE, Pierre S Rohrlich
Publikováno v:
Blood
Blood, 2015, 126 (14), pp.1643--1650. ⟨10.1182/blood-2015-03-634493⟩
Blood, American Society of Hematology, 2015, 126 (14), pp.1643--1650. 〈10.1182/blood-2015-03-634493〉
Blood, American Society of Hematology, 2015, 126 (14), pp.1643--1650. ⟨10.1182/blood-2015-03-634493⟩
Blood, 2015, 126 (14), pp.1643--1650. ⟨10.1182/blood-2015-03-634493⟩
Blood, American Society of Hematology, 2015, 126 (14), pp.1643--1650. 〈10.1182/blood-2015-03-634493〉
Blood, American Society of Hematology, 2015, 126 (14), pp.1643--1650. ⟨10.1182/blood-2015-03-634493⟩
International audience; Severe chronic primary neutropenia (CPN) is a rare entity, and long-term outcome and risk factors for infections in severe CPN adults have not been described to date. We report the characteristics and outcomes of 108 severe ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a30a8fb06c6b02d6ae11e9bd9eed8ae2
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01255845
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01255845
Autor:
Muriel Giansily Blaizot, Christine Biron-Andreani, Patricia Aguilar-Martinez, Philippe De Moeloose, Marie-Elisabeth Briquel, Jenny Goudemand, Nathalie Stieltjes, Claire Barrot, Herve Chambost, Anne Durin, Valerie Gay, Jocelyne Peynet, Katia Pouymayou, Jean-François Schved
Publikováno v:
British Journal of Haematology. 117:172-175
Inherited factor VII (FVII) deficiency is a rare autosomal disorder characterized by a weak relationship between FVII activity (FVII:C) and operative bleeding risk. We report a retrospective study of 17 patients with a FVII:C below 0.1 IU/ml, in whom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ade8f9ed8421d4f146e6aeae0803197
https://doi.org/10.1046/j.1365-2141.2002.03408.x
https://doi.org/10.1046/j.1365-2141.2002.03408.x
Autor:
Roseline D'Oiron, Antoine Rauch, Sandrine MEUNIER, Cecile Denis, Benoit Guillet, Yesim Dargaud, Sophie Susen, Sophie VOISIN, Yohann REPESSE, HERVE CHAMBOST, Claude Negrier, Michaela Fontenay, Jean-Christophe GRIS, Valerie Proulle, Anne Lienhart, Jean-Francois Schved, Valérie Chamouard
Publikováno v:
Medicine. 95:e3038
von Willebrand disease (VWD) is a genetic bleeding disease due to a defect of von Willebrand factor (VWF), a glycoprotein crucial for platelet adhesion to the subendothelium after vascular injury. VWD include quantitative defects of VWF, either parti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::feae36ea541b73630e439bb31af32f6f
https://doi.org/10.1097/md.0000000000003038
https://doi.org/10.1097/md.0000000000003038
Autor:
HERVE CHAMBOST, Van Baren N, Brasseur F, Godelaine D, Xerri L, Sj, Landi, Theate I, Plumas J, Gc, Spagnoli, Michel G, Pg, Coulie, Olive D
Publikováno v:
Europe PubMed Central
Genes of the MAGE-A family are expressed in several types of solid tumors but are silent in normal tissues with the exception of male germline cells, which do not carry HLA molecules.Therefore, peptides encoded by MAGE-A genes are strictly tumor-spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::684f44a07ba720ca174a935eb8ea73f0
https://pubmed.ncbi.nlm.nih.gov/10828039
https://pubmed.ncbi.nlm.nih.gov/10828039
Publikováno v:
Europe PubMed Central
We evaluated the long-term side-effects of allogeneic BMT performed early in the course of childhood acute leukaemia (first complete remission and interval between diagnosis and BMT not exceeding 6 months). Thirteen patients fulfilled these criteria.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b8437200ff9484d584c1fb385f1d6ee0
https://pubmed.ncbi.nlm.nih.gov/7599556
https://pubmed.ncbi.nlm.nih.gov/7599556
Publikováno v:
Europe PubMed Central
We report a clinically isolated toxoplasma pneumonitis in a child treated by HLA haplo-mismatched BMT. Conditioning consisted of TBI, cytarabine and melphalan. The BM graft was T-depleted and the boy received iv moAb antiLFA1 and antiCD2. The clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fc3b8787e56156fe2c34425e0b455461
https://pubmed.ncbi.nlm.nih.gov/7994272
https://pubmed.ncbi.nlm.nih.gov/7994272